Pressroom: Media Coverage

Showing 361 - 380 of 555 news items

2012

Advances in Bladder Cancer Treatment Around the Corner

Urologic surgeon Harry Herr talked about current treatment options for bladder cancer and the research under way to bring new treatments to patients.

March 14, 2012
Pursuing an Ethic of Service: Lung Cancer Researcher Noted for Drug Discovery, Charitable Works

In this profile piece, Thoracic Oncology Service Chief Mark Kris discussed his career, current research interests, and charitable work. He said, “I’ve heard people say that, if you choose the right profession or job, you’ll never have to work a day in your life, and I feel like that.”

March 13, 2012
Many with Cancer Pain Aren't on Strong Painkillers

Pain and Palliative Care Service Chief Paul Glare commented on a study that found that one in three older cancer patients are not taking opioids to treat their pain. Dr. Glare said that if patients feel their pain is not being addressed by their doctor, they should ask to see a pain specialist for treatment.

March 9, 2012
Radiation Blast May Turbocharge Bristol-Myers Melanoma Drug

Medical oncologist Jedd Wolchok discussed a unique single-patient study that demonstrates a rare phenomenon called the abscopal effect, in which radiation to just one tumor causes other tumors all over the body to regress. The patient studied took ipilimumab (Yervoy™), a drug that stimulates the immune system to fight cancer cells, but did not respond to the medicine until she got a radiation treatment.

March 8, 2012
New Treatment Successfully Targets Tumors

Medical oncologist Jedd Wolchok and his patient Valerie Esposito spoke about the rare medical phenomenon she experienced when local radiation to just one tumor caused other tumors in her body to shrink. Dr. Wolchok said, “We’re very excited about this result because we treated just one tumor with radiation therapy in this patient, and as a result, distant tumors regressed.”

March 7, 2012
Answers in Medicine Sometimes Lie in Luck

Infectious disease specialist Kent Sepkowitz authored this essay about doctors who believe in luck. He said that despite the endless evidence demonstrating its nonexistence, all doctors believe in luck because most of what happens to patients still falls well outside their understanding.

March 6, 2012
Meaning-Based Therapy May Aid Terminal Patient

Psychiatry Service Chief William Breitbart discussed his study that found that talk therapy sessions focused on spirituality and finding meaning improved quality of life and well-being in terminally ill cancer patients. Dr. Breitbart said, “What’s critical for cancer patients is for them to understand that even with advanced cancer, there is always the possibility for the experience of meaning, even in the last days of life.”

March 2, 2012
“Chemobrain” May Linger 20 Years after Breast Cancer Treatment

New research suggests that “chemobrain,” the name given to the mental fog and related memory problems that can occur during and after chemotherapy, may last for two decades after breast cancer treatment. Psychologist Tim Ahles said the new study is the first to illustrate that long-term breast cancer survivors still experience difficulty with their thought processes.

February 27, 2012
Report Affirms Lifesaving Role of Colonoscopy

A new study led by epidemiologist Ann Zauber and gastroenterologist Sidney Winawer found that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease. Although many people have assumed that colonoscopy must save lives because it is so often recommended, strong evidence has been lacking until now.

February 23, 2012
Colonoscopy Cuts Colon Cancer Death Risk

Gastroenterologist Sidney Winawer spoke about a study he co-authored with epidemiologist Ann Zauber that shows for the first time that colonoscopies save lives. A second study in Europe found that colonoscopies did a better job of finding polyps than tests that look for blood in stool, another common screening tool.

February 22, 2012
New Hospital Cuisine: Dishes Made to Order

Chemotherapy can dramatically affect a patient’s appetite, tastes, and diet. Executive Chef Pnina Peled talked about a growing trend among hospitals to revamp their kitchens and offer more-personalized menu items for patients with a variety of nutritional needs. Food and Nutrition Services Director Veronica McLymont was also quoted.

February 21, 2012
Clinical Trials Network Aims to Strengthen Cancer Immunotherapy Pipeline

Medical oncologist Jedd Wolchok spoke about a new initiative called the Cancer Immunotherapy Trials Network (CITN). Dr. Wolchok is one of 27 researchers chosen from the nation’s top cancer centers and universities to lead clinical trials to spur the development of cancer treatments that work by revving up the immune system’s response to tumors.

February 21, 2012
What's the Cure in the Race against Breast Cancer?

Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton was interviewed about prevention and treatment innovations for breast cancer patients. He said, “There are a lot of very exciting things that are moving forward, and it’s all based on a new understanding of the biology of cancer.”

NPR
February 19, 2012
Fake Cancer Drug Found in US

Gastrointestinal Oncology Acting Chief Leonard Saltz spoke about a counterfeit version of Avastin found in the United States. Counterfeiting has historically been more of a problem outside the US, and experts say counterfeits are a relatively small but still serious problem for the nation’s drug supply. Avastin is a commonly used drug for patients with colon, lung, and other cancers.

February 15, 2012
Rare Mutations Tied to Breast, Pancreatic Cancers

The inherited genetic mutations that can lead to Lynch syndrome may put people at extra risk for breast and pancreatic cancer, in addition to their well-known ties to colon and endometrial cancers, a new report found. Pathologist Jinru Shia was quoted.

February 15, 2012
Livingston Cancer Victim Lives On through Cycling Fundraiser

Memorial Sloan Kettering patient Jennifer Goodman Linn co-founded Cycle for Survival, an indoor cycling event that started as a single-gym fundraiser with a five-figure goal but has now raised more than $14 million for cancer research. Her oncologist, Gary Schwartz, was quoted.

February 10, 2012
Girl Riddled with Cancer Tumors Now in Remission after Pioneering Treatment in US

8H9, a promising new treatment that targets neuroblastoma cells, is helping two-year-old Lilly MacGlashan beat cancer. Lilly’s pediatric oncologist, Kim Kramer, said, “We have made great progress and have treated plenty of children who have beaten this and gone on to live good lives without the cancer coming back anywhere in their bodies.”

February 7, 2012
Daughter Diagnosed with Leukemia Inspires Father to Ride

Christopher Sarro, whose daughter was diagnosed with leukemia last year, is participating in this year’s Cycle for Survival to raise funds for cancer research at Memorial Sloan Kettering. The indoor cycling event, co-founded in 2007 by Jennifer Goodman Linn, who lost her battle with cancer last year, is Memorial Sloan Kettering’s most successful patient-run fundraiser to date. Ms. Linn’s oncologist, Gary Schwartz, was quoted.

February 6, 2012
Experimental Drug Shows Promising Results for Men with Prostate Cancer

Memorial Sloan Kettering patient John O’Mara and his oncologist, Daniel Danila, spoke about the investigational oral drug MDV3100, which is improving outcomes in patients with advanced prostate cancer. Mr. O’Mara, a clinical trial subject who is receiving the drug, said, “I do look at the future, even though I’m quite an old man, with a great deal more confidence.”

NY1
February 6, 2012
The Cure for the Common Hospital

Pediatric oncologist Kim Kramer talked about life in the pediatrics department and what makes Memorial Sloan Kettering unique from other cancer treatment centers.

February 3, 2012